Towards Healthcare
Liquid Biopsy Tube Market Uplift USD 1.54 Billion in 2025

Liquid Biopsy Tube Market Forecast 2025 Innovation in DNA & RNA Tubes to Drive 14.85% CAGR Growth Till 2034

According to market projections, the liquid biopsy tube sector is expected to grow from USD 1.34 billion in 2024 to USD 5.32 billion by 2034, reflecting a CAGR of 14.85%. These specialized tubes offer a revolutionary alternative to traditional biopsy methods by improving patient comfort and enabling real-time disease monitoring.

Content

  • Last Updated: 01 November 2025
  • Report Covered: [Revenue + Volume]
  • Historical Year: 2021-2023
  • Base Year: 2024
  • Estimated Years: 2025-2034

About The Author

Deepa Pandey is a focused and detail-oriented market research professional with growing expertise in the healthcare sector, delivering high-quality insights across therapeutic areas, diagnostics, biotechnology, and healthcare services.

She began her research career at Precedence Research, where she contributed to a wide range of healthcare industry studies, helping build a strong foundation in market intelligence and strategic research. Currently, Deepa plays a critical role at Towards Healthcare, while also extending her research capabilities across Statifacts, supporting cross-industry intelligence initiatives with a focus on healthcare.

Her ability to distill complexity into clarity has made her a trusted contributor to both internal teams and external clients across the healthcare value chain. By combining professionalism with an evolving depth in healthcare research, Deepa consistently adds value to projects that demand critical thinking, market precision, and industry-specific knowledge. Her contributions help organizations navigate the complexities of regulated markets and make data-backed growth decisions.

Talk to us
FAQ's

The liquid biopsy tube market is projected to reach USD 5.32 billion by 2034, growing at a CAGR of 14.85% from 2024 to 2034.

North America is currently leading the Liquid Biopsy Tube market, due to a robust healthcare infrastructure and extensive funding in molecular diagnostics, prestigious clinical reference laboratories, and prominent oncology centers commonly utilize of DNA and RNA tubes for precise testing.

The market includes five segments such as Tube Type, additive preservation chemistry, application, end-user, and material.

Some key players include Streck, Inc., and Bio-Rad Laboratories, Inc.

Key trends include rising demand for minimally invasive diagnostics and advancements in precision oncology.

Ministry of Health and Family Welfare, Government of India, National Institutes of Health, FDA, WHO, PIB, CDC.
Any Questions